Seoul National University Hospital opens living lab to promote early autism diagnosis
Seoul National University Hospital in South Korea has opened a living laboratory which aims to promote the early diagnosis and personalised treatment of autism spectrum disorder.
The lab, which consists of four spaces: an interaction room, a gaze tracking room, an observation room, and a family counselling room, will collect live health data from children with autism, such as voice, language, and gaze.
These data will be used to develop AI models for the early diagnosis and personalised treatment of autism.
The lab, which is established as part of a project by the National Center for Mental Health under the Ministry of Health and Welfare, will also serve as the bedrock of various digital treatments and the discovery of biomarkers for autism.
Aster DM Healthcare launches digital health centre in India
Aster DM Healthcare has set up a telecommand centre and digital health office in Bengaluru, India.
According to a press release, the centre allows a team of skilled medical professionals to monitor and treat patients remotely in real time. It also serves as the backbone of the hospital’s range of telehealth operations in India, including virtual consultations, remote patient monitoring, teleICU, teleradiology, and other telemedicine-based interventions.
“With the new initiative, we can now offer the expertise of our talented medical professionals beyond physical boundaries to patients and professionals across the world,” said Dr Azad Moopen, Aster DM founding chairman and managing director.
Meanwhile, Aster DM will also launch myAster, its omnichannel offering of healthcare services, in India shortly.
South Korean partnership to use AI for building rare diseases knowledge base
SNUH has also recently announced a partnership with the Mogam Institute for Biomedical Research to build a knowledge base of rare diseases using AI.
Based on a press statement, the knowledge base will help collect and interpret information on the causes, symptoms, and genetics of rare diseases for diagnosis and treatment.
The Mogam Institute will develop AI algorithms for building the said knowledge base while SNUH will review the available data.
Saitama Medical University Hospital to validate AI for migraine diagnosis
Saitama Medical University Hospital in Japan has tied up with US-based healthcare AI company Healint to conduct what could be the world’s first clinical study on AI headache diagnosis.
The study, according to a press statement, aims to validate the AI on Healint’s Migraine Buddy application for detecting patterns of migraine.
This content was originally published here.